Diabetic Kidney Disease and the Cardiorenal Syndrome Old Disease, New Perspectives

被引：27

作者：

Jindal, Ankur ^{[1
,2
]}

Garcia-Touza, Mariana ^{[2
,3
]}

Jindal, Nidhi ^{[4
]}

Whaley-Connell, Adam ^{[2
,3
,4
,5
]}

Sowers, James R. ^{[2
,3
,5
,6
]}

机构：

[1] Univ Missouri, Dept Internal Med, Hosp Med, Columbia, MO 65212 USA

[2] Univ Missouri, Diabet & Cardiovasc Res Ctr, Columbia, MO 65212 USA

[3] Univ Missouri, Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab, Columbia, MO 65212 USA

[4] Univ Missouri, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Columbia, MO 65212 USA

[5] Harry S Truman Mem Vet Hosp, Dept Internal Med, Columbia, MO 65201 USA

[6] Univ Missouri, Dept Med Physiol & Pharmacol, Columbia, MO 65212 USA

来源：

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2013年 / 42卷 / 04期

关键词：

Diabetes; Cardiorenal syndrome; Diabetic nephropathy; Chronic kidney disease; Blood pressure variability; Albuminuria; Proteinuria; BLOOD-PRESSURE VARIABILITY; GLOMERULAR-FILTRATION-RATE; TO-VISIT VARIABILITY; NONALBUMINURIC RENAL-INSUFFICIENCY; ANGIOTENSIN-RECEPTOR BLOCKADE; RISK-FACTORS; CARDIOVASCULAR OUTCOMES; GLYCEMIC CONTROL; PROGNOSTIC-SIGNIFICANCE; THERAPEUTIC APPROACH;

D O I：

10.1016/j.ecl.2013.06.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In this article,the-literature is reviewed regarding the role of blood pressure variability and nocturnal nondipping of blood pressure as well as the presence of diabetic kidney disease (DKD), in the absence of albuminuria, as risk predictors for progressive DKD. The importance of glycemic and blood presure control in patients with diabetes and chronic kidney disease, and the use of oral hypoglycemic agents and antihypertensive agents in this patient cohort, are also discussed.

引用

页码：789 / +

页数：21

共 90 条

[1] Antidiabetic Agents in Patients with Chronic Kidney Disease and End-Stage Renal Disease on Dialysis: Metabolism and Clinical Practice
Abe, Masanori
Okada, Kazuyoshi
Soma, Masayoshi
[J]. CURRENT DRUG METABOLISM, 2011, 12 (01) : 57 - 69
[2] DPP-4 Inhibition on Top of Angiotensin Receptor Blockade Offers a New Therapeutic Approach for Diabetic Nephropathy
Alter, Markus L.
Ott, Ina M.
von Websky, Karoline
Tsuprykov, Oleg
Sharkovska, Yuliya
Krause-Relle, Katharina
Raila, Jens
Henze, Andrea
Klein, Thomas
Hocher, Berthold
[J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2012, 36 (01) : 119 - 130
[3] Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365
[4] [Anonymous], NEPHROL DIAL TRANSPL
[5] [Anonymous], NEW ENGL J MED
[6] [Anonymous], AM J THER
[7] [Anonymous], NAT CHRON KIDN DIS F
[8] [Anonymous], HYPERTENS RES
[9] Assessing glycemic control in patients with diabetes and end-stage renal failure
Ansari, A
Thomas, S
Goldsmith, D
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (03) : 523 - 531
[10] National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events
Bakris, George
Vassalotti, Joseph
Ritz, Eberhard
Wanner, Christoph
Stergiou, George
Molitch, Mark
Nesto, Richard
Kaysen, George A.
Sowers, James R.
[J]. KIDNEY INTERNATIONAL, 2010, 78 (08) : 726 - 736

← 1 2 3 4 5 6 7 8 9 →